800 community pharmacies participate in Dispose My Meds campaign launch
ALEXANDRIA, Va. Nearly 800 community pharmacies in 40 states are making it easier than ever for consumers to safely dispose of unused patient medications at their local pharmacy with the help of the Dispose My Meds campaign, headed by the National Community Pharmacists Association, Sharps Compliance and the Community Anti-Drug Coalitions of America.
As previously reported by Drug Store News, Dispose My Meds is designed to provide consumers with unprecedented options to safely and responsibly dispose of unused medications at hundreds of participating community pharmacies nationwide. A new Web site, DisposeMyMeds.org, allows consumers to search for a participating pharmacy disposal program by city, state, or zip code. Some exclusions apply. NCPA is encouraging other community pharmacies to voluntarily sign up for the program in coming weeks and months as part of an on-going effort.
“Safe and practical disposal programs make a real difference in addressing this growing public health concern,” said Joseph Harmison, NCPA president and pharmacy owner. “I commend these pharmacies for stepping up for the good of their communities and their patients. And, hopefully, consumers will gain a greater appreciation of their local community pharmacy. I also appreciate the support our allies and sponsors have shown for this effort.”
The Dispose My Meds effort builds on the success of the work of the Iowa Pharmacy Association to enroll 300+ pharmacies in the state in a drug disposal program launched in November 2009. Many pharmacies are using the products of TakeAway Environmental Return System, via a recent partnership between NCPA and Sharps Compliance.
“We are proud to work with NCPA and its membership to more efficiently and effectively address the problem pharmacists, patients and communities face with unused patient medication,” said Claude A. Dance, Sharps Compliance SVP sales and marketing. “It also gives patients and pharmacists’ proactive adherence and counseling opportunities to ensure patients are taking the meds as prescribed by their physician as well as a way to safely discard their unused medications and keep our communities safer.”
Sponsors of the program include AstraZeneca, Apotex, Covidien, King Pharmaceuticals, the Community Pharmacy Foundation and the Cardinal Health Foundation.
FDA approves Toprol XL generic
MORRISTOWN, N.J. The Food and Drug Administration has approved a generic version of a drug for treating heart disease made by Watson Pharmaceuticals, Watson announced Thursday.
The FDA approved Watson’s metoprolol succinate extended-release tablets in the 100-mg and 200-mg strengths. The drug is used to treat angina, heart failure and hypertension.
The tablets are a generic version of AstraZeneca’s Toprol XL, which had sales of $403 million during the 12-month period ended in February, according to IMS Health.
NCPA, partners launch Dispose My Meds campaign
ALEXANDRIA, Va. A group representing the nation’s independent pharmacists will be kicking off a campaign with Sharps Compliance and the Community Anti-Drug Coalitions of America to address ways consumers can safely dispose prescription medications.
The National Community Pharmacists Association said the Dispose My Meds campaign, an official Earth Day activity, will provide consumers with unprecedented options to safely and responsibly dispose of unused medications at hundreds of participating community pharmacies nationwide.
More than four billion prescriptions are written annually in the United States, according to estimates, and up to 40% of drugs dispensed outside of hospitals go unused, generating some 200 million pounds of pharmaceutical waste each year, NCPA said. Additionally, NCPA said, unused patient medications are a contributor to traces of pharmaceuticals being found in America’s drinking water and accidental poisonings, which have involved an 80% increase in U.S. deaths from accidental overdose of narcotics in a recent six-year period.
NCPA president Joe Harmison, in addition to Claude Dance, Sharps Compliance SVP sales and marketing, and Mark Elizabeth Elliott, Community Anti-Drug Coalitions of America VP communications, membership and IT, will host a conference call April 19 to discuss the initiative. For more information or to RSVP, please contact John Norton, NCPA, at 703-600-1174 or email@example.com.